vs
HERON THERAPEUTICS, INC.（HRTX）与Rumble Inc.（RUM）财务数据对比。点击上方公司名可切换其他公司
HERON THERAPEUTICS, INC.的季度营收约是Rumble Inc.的1.5倍（$40.6M vs $27.1M），HERON THERAPEUTICS, INC.净利率更高（-7.3% vs -120.8%，领先113.5%），HERON THERAPEUTICS, INC.同比增速更快（-0.5% vs -10.5%），过去两年Rumble Inc.的营收复合增速更高（15.2% vs 8.2%）
安提贝制药是一家总部位于多伦多的制药企业，由曾参与创立全球首个气态介质药物开发企业NicOx的约翰·L·华莱士创立于2009年。该企业专注于依托气态介质技术研发缓解疼痛与炎症的药物，2013年在多伦多风险交易所挂牌，2015年收购再生医学领域经销商Citagenix，2020年11月转板多伦多证券交易所。
Rumble Inc.是一家加美跨国企业，主营在线视频平台、网络托管及云服务，总部位于加拿大多伦多，美国总部设在佛罗里达州朗博特基。公司由加拿大科技创业者克里斯·帕夫洛夫斯基于2013年创立，云服务板块为Truth Social提供托管支持，其视频平台在美国保守派及极右翼用户群体中广受欢迎，属于“另类科技”阵营。
HRTX vs RUM — 直观对比
营收规模更大
HRTX
是对方的1.5倍
$27.1M
营收增速更快
HRTX
高出10.0%
-10.5%
净利率更高
HRTX
高出113.5%
-120.8%
两年增速更快
RUM
近两年复合增速
8.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.6M | $27.1M |
| 净利润 | $-3.0M | $-32.7M |
| 毛利率 | 72.6% | 5.5% |
| 营业利润率 | 0.1% | -131.1% |
| 净利率 | -7.3% | -120.8% |
| 营收同比 | -0.5% | -10.5% |
| 净利润同比 | -180.6% | 86.2% |
| 每股收益（稀释后） | $-0.01 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HRTXRUM
| Q4 25 | $40.6M | $27.1M | ||
| Q3 25 | $38.2M | $24.8M | ||
| Q2 25 | $37.2M | — | ||
| Q1 25 | $38.9M | $23.7M | ||
| Q4 24 | $40.8M | $30.2M | ||
| Q3 24 | $32.8M | $25.1M | ||
| Q2 24 | $36.0M | $22.5M | ||
| Q1 24 | $34.7M | $17.7M |
净利润HRTXRUM
| Q4 25 | $-3.0M | $-32.7M | ||
| Q3 25 | $-17.5M | $-16.3M | ||
| Q2 25 | $-2.4M | — | ||
| Q1 25 | $2.6M | $-2.7M | ||
| Q4 24 | $3.7M | $-236.8M | ||
| Q3 24 | $-4.8M | $-31.5M | ||
| Q2 24 | $-9.2M | $-26.8M | ||
| Q1 24 | $-3.2M | $-43.3M |
毛利率HRTXRUM
| Q4 25 | 72.6% | 5.5% | ||
| Q3 25 | 68.8% | -1.8% | ||
| Q2 25 | 73.5% | — | ||
| Q1 25 | 78.3% | -26.7% | ||
| Q4 24 | 74.9% | -14.2% | ||
| Q3 24 | 71.2% | -45.4% | ||
| Q2 24 | 70.8% | -58.8% | ||
| Q1 24 | 75.6% | -79.5% |
营业利润率HRTXRUM
| Q4 25 | 0.1% | -131.1% | ||
| Q3 25 | -10.7% | -113.6% | ||
| Q2 25 | -4.4% | — | ||
| Q1 25 | 8.1% | -153.5% | ||
| Q4 24 | 10.2% | -80.1% | ||
| Q3 24 | -13.6% | -131.0% | ||
| Q2 24 | -17.9% | -172.7% | ||
| Q1 24 | -13.8% | -197.4% |
净利率HRTXRUM
| Q4 25 | -7.3% | -120.8% | ||
| Q3 25 | -45.8% | -65.7% | ||
| Q2 25 | -6.4% | — | ||
| Q1 25 | 6.8% | -11.2% | ||
| Q4 24 | 9.0% | -783.2% | ||
| Q3 24 | -14.8% | -125.9% | ||
| Q2 24 | -25.6% | -119.2% | ||
| Q1 24 | -9.1% | -244.1% |
每股收益（稀释后）HRTXRUM
| Q4 25 | $-0.01 | $-0.13 | ||
| Q3 25 | $-0.10 | $-0.06 | ||
| Q2 25 | $-0.02 | — | ||
| Q1 25 | $0.01 | $-0.01 | ||
| Q4 24 | $0.02 | $-1.17 | ||
| Q3 24 | $-0.03 | $-0.15 | ||
| Q2 24 | $-0.06 | $-0.13 | ||
| Q1 24 | $-0.02 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $28.6M | $237.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $14.3M | $274.8M |
| 总资产 | $255.9M | $336.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HRTXRUM
| Q4 25 | $28.6M | $237.9M | ||
| Q3 25 | $43.1M | $269.8M | ||
| Q2 25 | $16.5M | — | ||
| Q1 25 | $19.3M | $301.3M | ||
| Q4 24 | $25.8M | $114.0M | ||
| Q3 24 | $25.7M | $132.0M | ||
| Q2 24 | $18.4M | $154.2M | ||
| Q1 24 | $20.4M | $183.8M |
股东权益HRTXRUM
| Q4 25 | $14.3M | $274.8M | ||
| Q3 25 | $14.9M | $302.2M | ||
| Q2 25 | $-27.3M | — | ||
| Q1 25 | $-28.5M | $339.6M | ||
| Q4 24 | $-33.7M | $-63.1M | ||
| Q3 24 | $-40.0M | $166.1M | ||
| Q2 24 | $-37.9M | $192.7M | ||
| Q1 24 | $-33.8M | $210.7M |
总资产HRTXRUM
| Q4 25 | $255.9M | $336.8M | ||
| Q3 25 | $248.9M | $367.2M | ||
| Q2 25 | $232.1M | — | ||
| Q1 25 | $235.8M | $391.1M | ||
| Q4 24 | $233.1M | $195.3M | ||
| Q3 24 | $220.8M | $217.2M | ||
| Q2 24 | $218.1M | $243.2M | ||
| Q1 24 | $217.9M | $263.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.2M | $-29.4M |
| 自由现金流经营现金流 - 资本支出 | — | $-31.7M |
| 自由现金流率自由现金流/营收 | — | -117.2% |
| 资本支出强度资本支出/营收 | 0.0% | 8.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-70.8M |
8季度趋势，按日历期对齐
经营现金流HRTXRUM
| Q4 25 | $-9.2M | $-29.4M | ||
| Q3 25 | $1.3M | $-10.6M | ||
| Q2 25 | $-10.9M | — | ||
| Q1 25 | $-8.9M | $-14.5M | ||
| Q4 24 | $-11.8M | $-12.4M | ||
| Q3 24 | $3.4M | $-19.1M | ||
| Q2 24 | $-4.6M | $-21.7M | ||
| Q1 24 | $-9.5M | $-33.9M |
自由现金流HRTXRUM
| Q4 25 | — | $-31.7M | ||
| Q3 25 | — | $-12.0M | ||
| Q2 25 | $-11.1M | — | ||
| Q1 25 | $-9.0M | $-14.6M | ||
| Q4 24 | — | $-12.4M | ||
| Q3 24 | $2.9M | $-19.9M | ||
| Q2 24 | — | $-23.1M | ||
| Q1 24 | — | $-34.3M |
自由现金流率HRTXRUM
| Q4 25 | — | -117.2% | ||
| Q3 25 | — | -48.6% | ||
| Q2 25 | -29.8% | — | ||
| Q1 25 | -23.1% | -61.7% | ||
| Q4 24 | — | -40.9% | ||
| Q3 24 | 9.0% | -79.5% | ||
| Q2 24 | — | -102.8% | ||
| Q1 24 | — | -193.3% |
资本支出强度HRTXRUM
| Q4 25 | 0.0% | 8.5% | ||
| Q3 25 | 0.0% | 5.7% | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.3% | 0.6% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 1.3% | 3.4% | ||
| Q2 24 | — | 6.1% | ||
| Q1 24 | — | 2.4% |
现金转化率HRTXRUM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -3.37× | — | ||
| Q4 24 | -3.22× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HRTX
| CINVANTI | $22.9M | 56% |
| ZYNRELEF | $12.5M | 31% |
| Aponvie | $3.8M | 9% |
| SUSTOL | $1.3M | 3% |
RUM
| Audience Monetization | $23.8M | 88% |
| Other Initiatives | $3.3M | 12% |
